R&D Capitalization: A Simple Guide to Journal Entries
R&D capitalization means recording a research and development (R&D) cost as an asset. Under U.S. generally accepted accounting principles (GAAP), ASC 730 requires most R&D costs to be expensed as incurred. The exception is equipment, materials, facilities, or purchased intangibles with an alternative future use. Those are capitalized, and the portion used up in research becomes R&D expense.
The key question is what the company bought and how it can use that resource. Capitalizing a reusable laboratory machine does not mean capitalizing the research project itself. This distinction often determines the correct answer to an Intermediate Accounting problem.
Quick note: this guide covers financial reporting under U.S. GAAP. If you are looking for the IFRS rule on development costs, software capitalization, or the tax rule in IRC Section 174 and Section 174A, jump to Other meanings of R&D capitalization below.
Video lesson with Professor Farhat
Start at 5:39 for Professor Farhat’s worked classification example. Follow the equipment purchase and its depreciation as separate accounting steps.
Watch Accounting for Research and Development Costs on YouTube.
When can R&D costs be capitalized? Start with the resource
Capitalize means record a cost as an asset. Expense means recognize the cost in current earnings. For materials, equipment, and facilities acquired for R&D, ask whether there is an alternative future use in another research project or another business activity.
The alternative must concern the resource itself. “We hope the experimental product sells well” is not the same as “This machine can be used in other identified projects.” A long physical life also does not prove alternative future use if the equipment is useful only for one experiment.
| Resource or cost | Initial treatment | Expense treatment |
|---|---|---|
| Special equipment with no alternative future use | Expense as R&D when incurred | No later depreciation of an asset never recognized |
| Equipment usable in other projects | Capitalize as equipment | Depreciation used in research is R&D expense |
| Materials usable in current and future projects | Record as materials inventory | Charge amounts consumed in research to R&D |
| Research wages and outside testing services | Expense as incurred | Do not defer because a project looks promising |
The FASB’s research-cost discussion explains the alternative-use distinction and cites Accounting Standards Codification (ASC) 730-10-25. First check whether the activity is research at all using the guide to research and development costs.
How do you record R&D equipment? Example and journal entries
Hypothetical example. Alder Instruments buys a testing machine for $96,000 on January 1. It can serve the current project and later projects. Its useful life is four years, its residual value is zero, and straight-line depreciation applies. It is available for use immediately and used entirely in R&D during Year 1.
| Event | Debit | Credit |
|---|---|---|
| Purchase | Equipment $96,000 | Cash $96,000 |
| Year 1 depreciation | R&D Expense $24,000 | Accumulated Depreciation—Equipment $24,000 |
Annual depreciation is $96,000 ÷ 4 = $24,000. The machine’s net carrying amount at year-end is $72,000. R&D expense includes $24,000 for using the machine, not its entire $96,000 purchase price.
Now change one fact: suppose the machine is specialized for this project and has no alternative future use. The purchase is expensed as R&D when incurred. Do not first expense $96,000 and then add another $24,000 of depreciation; that would count the cost twice.
Here is how the entries look when the machine has no alternative future use:
| Event | Debit | Credit |
|---|---|---|
| Purchase | R&D Expense $96,000 | Cash $96,000 |
| Year 1 depreciation | No entry | No entry |
The full $96,000 hits R&D expense once, in the year of purchase. There is no asset left to depreciate.
Materials, payroll, and the total expense
Alder also buys $15,000 of laboratory materials usable across several projects. It consumes $9,000 in Year 1. Record the purchase as Materials Inventory, then debit R&D Expense and credit Materials Inventory for the $9,000 consumed. The unused $6,000 remains an asset under the stated facts.
Assume researchers also earn $55,000, outside testing services cost $11,000, and reasonably allocated laboratory overhead is $8,000. R&D expense is:
$24,000 depreciation + $9,000 materials + $55,000 payroll + $11,000 testing + $8,000 overhead = $107,000.
Credit Cash or the appropriate payable for payroll and services, depending on whether payment has occurred. For overhead, credit the account the cost came from, such as Utilities Payable, or Accumulated Depreciation for an allocated share of building depreciation. The recognition of expense follows the work or resource consumption; it does not always follow the cash-payment date.
One more requirement: companies must disclose the total R&D cost charged to expense for each period in which an income statement is presented. In the Alder example, the Year 1 disclosure would include the $107,000.
Want more practice with entries like these? Professor Farhat’s Intermediate Accounting course covers R&D, intangible assets, and depreciation step by step. Not ready to commit? Try the free sample course first.
Purchased rights and patent costs need a separate check
Do not assume every purchased intangible is immediately expensed or every purchase is capitalized. In an asset acquisition, a purchased right for R&D generally needs an alternative future use to qualify for capitalization. Its amortization attributable to research then enters R&D expense.
An acquired in-process R&D project in a business combination follows a different initial recognition rule: recognize it at acquisition-date fair value and treat it as indefinite-lived until completion or abandonment. The FASB’s comparison of acquired R&D distinguishes these situations. Detailed acquisition accounting is beyond this lesson.
For amortization, impairment, and other intangible asset rules, see our intangible assets accounting guide.
Patent registration and qualifying legal costs are also different from the underlying experimental work. In the lesson’s basic patent examples, costs to obtain the patent and successfully defend it are capitalized to the patent. Previously expensed research is not added back. The account follows the nature of the cost, even when all invoices concern the same invention.
Buying research versus performing it for someone else
If Alder pays an outside laboratory to conduct Alder’s research, Alder ordinarily records R&D expense as the services are performed. If Alder instead performs work for a customer under a reimbursable contract, those costs are not automatically Alder’s own R&D expense.
For the lesson’s simple monthly-billable reimbursement situation, amounts recoverable from the client are recorded as a receivable. Actual contracts can require separate revenue and contract-cost analysis. Read who performs the work, who bears the cost, and what is billable before choosing an account.
Similarly, promoting the resulting product or opening a sales operation does not extend the R&D project indefinitely. Use the comparison of start-up and other related costs to identify those spending categories.
Other meanings of R&D capitalization: IFRS, software, and tax
The phrase R&D capitalization shows up in three other places. Each follows different rules from the ASC 730 approach above.
IFRS: development costs can become assets
Under IFRS (IAS 38, Intangible Assets), research costs are always expensed. Development costs must be capitalized as an intangible asset once a company can demonstrate all six of these:
- The technical feasibility of completing the asset
- Its intention to complete the asset and use or sell it
- Its ability to use or sell the asset
- How the asset will generate probable future economic benefits
- Adequate technical, financial, and other resources to finish it
- Reliable measurement of the development spending
If a company cannot separate the research phase from the development phase, it treats everything as research. This is a classic U.S. GAAP versus IFRS difference. See more in our FASB vs IASB guide.
Software: the main U.S. GAAP exception
For software that will be sold, leased, or otherwise marketed (ASC 985-20), costs are R&D expense until technological feasibility is established. After that, costs are generally capitalized until the product is available for general release to customers.
For internal-use software (ASC 350-40), eligible costs are capitalized once the capitalization criteria are met. Until a company adopts ASU 2025-06, the existing project-stage guidance continues to apply: preliminary-project costs are expensed, qualifying application-development costs are capitalized, and postimplementation operating costs are generally expensed.
Upon adoption, ASU 2025-06 replaces the project-stage model. Under the new test, capitalization begins when management has authorized and committed to funding the project, and it is probable that the project will be completed and the software will perform its intended function. If significant development uncertainty exists, that uncertainty must be resolved before the probable-to-complete threshold is met. ASU 2025-06 is effective for annual periods beginning after December 15, 2027, and early adoption is permitted as of the beginning of an annual reporting period.
One detail that trips students up: software a company develops for its own research activities is expensed as R&D.
Tax: IRC Section 174 and Section 174A
On a tax return, R&D capitalization usually refers to Internal Revenue Code (IRC) Section 174. For tax years beginning after December 31, 2021, the Tax Cuts and Jobs Act required businesses to capitalize research and experimental (R&E) costs. Domestic costs were amortized over 5 years and foreign costs over 15 years.
The One Big Beautiful Bill Act, signed July 4, 2025, added Section 174A. It lets businesses deduct domestic R&E costs immediately for tax years beginning after December 31, 2024. Businesses can instead elect to capitalize and amortize them. Foreign R&E is still amortized over 15 years. The law also created transition options for domestic costs capitalized in 2022 through 2024, including deducting the remaining balance over one or two years.
The Section 174A deduction does not apply to the purchase of depreciable research equipment. The $96,000 machine in this guide therefore does not qualify for an immediate deduction under Section 174A merely because it is used in research. Its purchase is subject to the applicable tax depreciation rules; qualifying depreciation allowances may be treated as research or experimental expenditures under Section 174A.
Because book rules and tax rules differ, the same R&D spending can be treated differently on the financial statements and the tax return. That gap can create deferred taxes.
Practice questions with explained answers
1. A $30,000 device has no use outside one experiment. The experiment will take two years. What is the initial entry?
Show answer and explanation
Answer: Debit R&D Expense $30,000 and credit Cash or Accounts Payable $30,000. The two-year project duration does not create an alternative use for the device.
2. Reusable research equipment costs $80,000, lasts five years, and has no residual value. What is one full year’s R&D depreciation?
Show answer and explanation
Answer: $16,000, assuming straight-line depreciation and exclusive research use. Capitalize the $80,000 purchase and expense its annual use through accumulated depreciation.
3. Research wages are $38,000, supplies consumed are $4,000, and research depreciation is $6,000. Unused reusable supplies cost $3,000. What is R&D expense?
Show answer and explanation
Answer: $48,000. Add wages, consumed supplies, and depreciation. The unused $3,000 remains materials inventory under the stated assumptions.
Key takeaways and exam traps
- Under U.S. GAAP (ASC 730), R&D costs are expensed as incurred.
- Equipment, materials, facilities, and purchased intangibles with an alternative future use are capitalized. The depreciation, amortization, or consumption from research use is R&D expense.
- Another R&D project counts as an alternative future use. A long useful life alone does not.
- Special equipment with no alternative use is expensed in full once. Do not also depreciate it.
- A prediction of success does not allow capitalization under U.S. GAAP. IFRS capitalizes development costs once six criteria are met.
Common exam traps:
- Counting both the purchase price and the depreciation of the same machine
- Expensing reusable materials that have not been used yet
- Adding previously expensed research costs to a patent
- Mixing up the financial reporting rule (ASC 730) with the tax rule (Section 174A)
Frequently asked questions
Does alternative future use require a nonresearch use?
No. Use in another R&D project can qualify. The important distinction is an alternative use beyond the particular project.
Can R&D capitalization begin when management predicts success?
No. Under U.S. GAAP, a forecast of success does not turn R&D spending into an asset. The costs are still expensed as incurred. The main exceptions come from other standards, such as software to be sold once technological feasibility is reached (ASC 985-20) and internal-use software (ASC 350-40). IFRS is different: it capitalizes development costs once specific criteria are met.
Does depreciation belong in R&D expense or depreciation expense?
Depreciation describes the cost’s nature; R&D describes its function. Depreciation of equipment used in research forms part of R&D expense. Allocate appropriately if the equipment serves more than one function.
Is R&D capitalized under IFRS?
Partly. IAS 38 expenses research costs but requires development costs to be capitalized once a company can show technical feasibility, intent and ability to complete and use or sell the asset, probable future economic benefits, adequate resources, and reliable measurement.
How are software development costs handled?
Software to be sold is expensed as R&D until technological feasibility, then generally capitalized until general release (ASC 985-20). Internal-use software is capitalized once the ASC 350-40 criteria are met. ASU 2025-06 updates those criteria for annual periods beginning after December 15, 2027.
Is R&D capitalization the same as the Section 174 tax rule?
No. ASC 730 is a financial reporting rule. Section 174 is a tax rule. After the One Big Beautiful Bill Act, Section 174A lets businesses deduct domestic research costs immediately for tax years beginning after December 31, 2024, while foreign research costs are still amortized over 15 years.
Which costs are not R&D at all?
Market research and market testing, routine quality control testing during commercial production, routine troubleshooting and ongoing refinements of existing products, and legal work on patent applications or litigation are not R&D under ASC 730. Classify them by their own nature instead.
Sources and lesson context
Reviewed: .
For the additional reporting frameworks and tax rules discussed above, consult FASB ASU 2025-06: Internal-Use Software, the IFRS Foundation’s IAS 38 overview, and IRC Section 174A: Domestic research or experimental expenditures.
This original guide supports Wiley Intermediate Accounting, section 11.4: Research and Development Costs. All numerical examples and practice questions here are hypothetical and were created for this guide. Use the reporting framework and assumptions stated in your assigned problem.
Continue learning: Intermediate Accounting course · Farhat Lectures free sample course.
About the author
Professor Mansour Farhat teaches accounting and exam preparation for CPA, CMA, and EA candidates at Farhat Lectures and on the Farhat Lectures YouTube channel.
Responses